Current Practice Patterns for Oral Chemotherapy: Results of a National Survey

Janna C. Roop

Horng-Shiuann Wu

ambulatory care, oral chemotherapy, chemotherapy, clinical practice, Patient education
ONF 2013, 41(2), 185-194. DOI: 10.1188/14.ONF.41-02AP

Purpose/Objectives: To describe current nursing practices in the United States regarding care and safety of patients taking oral chemotherapy.

Design: This three-phase study consisted of development, validation, and implementation of a national online survey.

Setting: Survey of oncology nurses in outpatient settings.

Sample: 577 oncology nurses.

Methods: Surveys were emailed to 5,000 members of the Oncology Nursing Society. The survey included 17 forced-choice items and one free-text item. Descriptive statistics and content analysis were obtained.

Main Research Variables: Patient care practices, nursing resources, and barriers to medication adherence.

Findings: Fifty-one percent of the respondents worked in practices that had developed specific policies, procedures, and resources for patients on oral chemotherapy. Barriers to treatment adherence included cost (81%) and adverse effects (72%). Practices with specific policies differed in clinical and statistical significance from practices without policies on almost every survey item. Free-text responses revealed that many practices have erratic procedures and inadequate interdisciplinary communication.

Conclusions: Systematic reliable policies and procedures for patient education, documentation, and interdisciplinary communication are urgently needed.

Implications for Nursing: Nurses should provide education and repeated teaching to improve patient safety, adherence to the medication, and self-monitoring for adverse effects.

Jump to a section


    Aisner, J. (2007). Overview of the changing pardigm in cancer treatment: Oral chemotherapy. American Journal of Health-System Pharmacy, 64(Suppl. 5), 54-57.
    Bedell, C.H., Hartigan, K.J., Wilkinson, K.I., & Halpern, I.M. (2002). Oral chemotherapy: Progress with challenges. Hematology Oncology News and Issues, 28-32.
    Birner, A.M., Bedell, M.K., Avery, J.T., & Ernstoff, M.S. (2006). Program to support safe administration of oral chemotherapy. Journal of Oncology Practice, 2, 5-6.
    Charpentier, M.M., Orr, K.K., & Taveira, T.H. (2012). Improving pharmacist knowledge of oral chemotherapy in the community. Annals of Pharmacotherapy, 46, 1205-1211. doi:10.1345/aph.1R056
    Chau, I., Legge, S., & Fumoleau, P. (2004). The vital role of education and information in patients receiving capecitabine (Xeloda). European Journal of Oncology Nursing, 8(Suppl. 1), S41-S53.
    Clancy, C.M. (2009). Ten years after To Err is Human. American Journal of Medical Quality, 24, 525-528. doi:10.1177/1062860609349728
    Findlay, M., von Minckwitz, G., & Wardley, A. (2008). Effective oral chemotherapy for breast cancer: Pillars of strength. Annals of Oncology, 19, 212-222.
    Gerbrecht, B., & Kangas, T. (2004). Implications of capecitabine (Xeloda) for cancer nursing practice. European Journal of Oncology Nursing, 8(Suppl. 1), S63-S71.
    Halcomb, E.J., Gholizadeh, L., DiGiacomo, M., Phillips, J., & Davidson, P.M. (2007). Literature review: Considerations in undertaking focus group research with culturally and linguistically diverse groups. Journal of Clinical Nursing, 16, 1000-1011.
    Hartigan, K. (2003). Patient education: The cornerstone of successful oral chemotherapy treatment. Clinical Journal of Oncology Nursing, 7(6, Suppl.), 21-24.
    Khandelwal, N., Duncan, I., Ahmed, T., Rubinstein, E., & Pegus, C. (2011). Impact of clinical oral chemotherapy program on wastage and hospitalizations. American Journal of Managed Care, 17, e169-e173.
    Kohn, L.T., Corrigan, J.M, & Donaldson, M.S. (Eds.). (2000). To err is human: Building a safer health system. Washington, DC: National Academies Press.
    Liu, G., Franssen, E., Fitch, M.I., & Warner, E. (1997). Patient preferences for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology, 15, 110-115.
    Moody, M., & Jackowski, J. (2010). Are patients on oral chemotherapy in your practice setting safe? Clinical Journal of Oncology Nursing, 14, 339-346. doi:10.1188/10.CJON.339-346
    Moore, S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing, 30, 112-122.
    Neuss, M.N., Polovich, M., McNiff, K., Esper, P., Gilmore, T.R., Lefebvre, K.B., … Jacobson, J.O. (2013). 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for the safe administration and management of oral chemotherapy. Oncology Nursing Forum, 40, 225-233. doi:10.1188/13.ONF.40-03AP2
    Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487-497.
    Palmieri, F.M., & Barton, D.L. (2007). Challenges of oral medications in patients with advanced breast cancer. Seminars in Oncology Nursing, 23(4, Suppl. 2), S17-S22.
    Smith, T.L., & Carter, C.W. (2010). Overview of chemotherapy and nine commonly prescribed chemotherapeutic medications. Journal of Pharmacy Technology, 26, 335-339.
    Staddon, A.P. (2011). Challenges of ensuring adherence to oral therapy in patients with solid malignancies. Community Oncology, 8, 254-262.
    Szetela, A.B., & Gibson, D.E. (2007). How the new oral antineoplastics affect nursing practice: Capecitabine serves to illustrate. American Journal of Nursing, 107(12), 40-49.
    Weingart, S.N., Flug, J., Brouillard, D., Morway, L., Partridge, A., Bartel, S., … Connor, M. (2007). Oral chemotherapy safety practices at U.S. cancer centres: Questionnaire survey. BMJ, 334, 407.
    Weingart, S.N., Li, J.W., Zhu, J., Morway, L., Stuver, S.O., Shulman, L.N., & Hassett, M.J. (2012). U.S. cancer center implementation of ASCO/Oncology Nursing Society chemotherapy administration safety standards. Journal of Oncology Practice, 8, 7-12. doi:10.1200/JOP.2011.000379
    Weingart, S.N., Mattsson, T., Zhu, J., Shulman, L.N., & Hassett, M. (2012). Improving electronic oral chemotherapy prescription: Can we build a safer system? Journal of Oncology Practice, 8, e168-e173. doi:10.1200/JOP.2012.000677
    Weingart, S.N., Spencer, J., Buia, S., Duncombe, D., Singh, P., Gadkari, M., & Connor, M. (2011). Medication safety of five oral chemotherapies: A proactive risk assessment. Journal of Oncology Practice, 7, 2-6. doi:10.1200/JOP.2010.000064
    Winkeljohn, D. (2007). Oral chemotherapy medications: The need for a nurse's touch. Clinical Journal of Oncology Nursing, 11, 793-796. doi: 10.1188/07.CJON.793-796
    Yagasaki, K., & Komatsu, H. (2013). The need for a nursing presence in oral chemotherapy. Clinical Journal of Oncology Nursing, 17, 512-516. doi: 10.1188/13.CJON.512-516